George Gauthier - 24 May 2022 Form 4 Insider Report for IGM Biosciences, Inc. (IGMS)

Role: Chief Commercial Officer
Signature: /s/ Misbah Tahir, by power of attorney
Issuer symbol: IGMS
Transactions as of: 24 May 2022
Transactions value $: -$22,917
Form type: 4
Filing time: 26 May 2022, 16:46:10 UTC
Previous filing: 17 May 2022
Next filing: 28 Nov 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IGMS	Common Stock	Sale	-$22.9K	-1.34K	-5.04%	$17.10	25.2K	24 May 2022	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
F2	This transaction was executed in multiple trades at prices ranging from $16.805 to $17.1269. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Content

These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.

This transaction was executed in multiple trades at prices ranging from $16.805 to $17.1269. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.